Guangyao apologize!The price of raw materials and medicines in the internal virtual raising
Author:Kenji Bureau Time:2022.08.10
After the State Medical Insurance Bureau reported, Guangyao Baiyun Mountain, who had a great cause, finally apologized.
On August 9th, the State Medical Insurance Bureau reported the relevant situation of the prices of virtual raw materials and the price of drug prices and funds for the price of Baiyunshan Tianxin Pharmaceutical, Baiyunshan, Baiyunshan,
From May 2017 to May 2021, in order to avoid the "two-vote system" policies and supervision, three pharmaceutical manufacturers including Tianxin Pharmaceuticals and more than 50 pharmaceutical agents in the lower reaches were colluded with each other, and 87 drugs purchased raw materials at virtual high prices. Methods cash out and transfer funds to downstream drug agents. The amount involves huge amounts, and some of them are used for bribery medical staff or specific relationship persons to carry out drug violations.
On the same day, CCTV's evening news also reported the incident.
On the evening of August 9th, the "Apologies" on the official website of Guangyao Baiyunshan said, saying that it has stopped cooperating with relevant agents and dealers to comprehensively rectify the marketing model, and conducts related products nationwide to reduce prices or withdraw from the network. Relevant responsible persons have been suspended from office, and those suspected of disciplinary violations are being investigated and punished according to law according to law.
Tuyuan Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. official website
The notification of the State Medical Insurance Administration revealed another secret price increase method in the pharmaceutical industry, which is more hidden than previously known "votes".
In fact, as early as 2019, things that Baiyun Shan's drugs increased costs had been exploded. Generally, it is really not easy for enterprises to do it.
Settlement techniques, general enterprises can't learn
According to the Medical Insurance Bureau, this is an illegal behavior of the dealers, pharmaceutical manufacturers, and pharmaceutical agents that are purchased by raw materials and drugs:
Guangyao Baiyun Mountain has a relatively complete "raw material -preparation" industry chain. Among them, raw materials are Baiyunshan Chemical Pharmaceutical Factory, and preparation companies are Baiyunshan Pharmaceutical. It stands to reason that the two companies belong to the same group, as long as they are supplied from raw materials to pharmaceutical companies.
However, in order to make high costs, Baiyunshan Pharmaceutical added a designated dealer in the procurement of raw materials. After the dealer purchases raw materials from the Baiyunshan Chemical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Factory , Get the difference from the middle set.
In this way, as a pharmaceutical manufacturer, Baiyunshan Pharmaceutical can require drug prices in the name of "raw drug price increase and high production cost".
This kind of act of acting between their own families, eventually raising the price of drugs, resulting in the price of the factory price and the bidding of the bidding network;
Finally, the raw material dealer transferred the difference between the cost to the drug agent for the medical business bribery.
This method can be described as one arrow and three sculptures: reasonably increase the price of drugs, and can also seize the market through commercial bribery. The most important thing is that this "cheating method" escapes the control scope of the two -vote system.
In the past, the industry generally believed that the price of drugs was high because there were too many sales links. The emergence of the "two -vote system" is to remove the layers of sales. There is only one dealer from the manufacturer to the hospital from the manufacturer to the hospital. Sold a ticket to the hospital.
The "two -vote system" controls the sales end, but cannot control the production side. Increase the price on the raw material and through reasonable demands, hoping to increase the price of the terminal product. This not only meets the "two -vote system" regulations, but also does not affect the price of drugs to increase drug prices.
This time, the State Medical Insurance Bureau named Bai Yunshan "injecting cephalosporin sulfur", and Guangyao Group could realize the entire production link from raw materials to preparations. As the first generation of cephalosporin antibiotics, the sales of cephalosporin sulfur sulfur injection have always been the main product of the Baiyunshan antibiotic field. In the three years from 2017 to 2019, this product has been selling the first five of Baiyunshan in the year, with revenue of 346 million yuan, 705 million yuan and 841 million yuan, respectively.
According to the Medical Insurance Bureau, 87 drugs illegally illegally used in the injection of cephalosporins like injecting of cephalosporin, which requires the price rectification as required. Above, some product regulations have been stopped purchased.
Previously, the company was denied by the company
The National Medical Insurance Bureau disclosed that the illegal time of Guangyao Baiyun Mountain was from May 2017 to May 2021. The old-fashioned state-owned enterprises did not rise for a while, and the violations also followed. As early as 3 years ago, there were already institutions that Baiyun Mountain had increased costs.
Tuyuan National Medical Security Bureau
In 2019, Kang Yeyuan, a partner of Guangyao Baiyunshan, released a "Open Letter" through the official WeChat signal, pointing out that Guangyao Group's suspected violation of the Securities Law and the Company Law.
In the "Public Letter", Kang Yeyuan pointed out: One of the procurement of Jin Ge raw materials is 1800 per kilogram, and when the head plant is at the head plant, it becomes one kg of 10,000 yuan. Directly transported from Shandong to the main factory warehouse.
At that time, Kangye Yuan had a dispute with Guangyao Baiyun Mountain due to the generic drug "Jin Ge", which is "Wan Aike", which was "Wan Aike", and therefore disclosed some internal information.
Guangyao Baiyun Mountain subsequently issued a clarification announcement stating that the production of "Jin Ge" requires more than 10 kinds of materials. The "1800 per kilogram of 1800" in the open letter is only one of them, and it cannot be understood as "Jin Ge" all raw materials. In 2018, the price of "Jin Ge" for the "Golden Ge" is about 8,600 yuan per kilogram, and the tax -included price is about 10,000 yuan per kilogram.
In addition to clarifying, Guangyao Baiyun Mountain also said that the report was not in line with the facts and had reported the case to the public security organs. In addition, in the past few years, Guangyao Baiyunshan has been watched by the media several times due to raw materials.
"Daily Economic News" reported in 2017, due to the rise in the cost of raw materials and the serious phenomenon of raw materials monopolies, dozens of life -saving pills in Guangdong have been disconnected. Among the breaking varieties, Baiyun Mountain is among them.
Soon, this disconnection was valued by local governments, and related companies enjoyed policy preferential treatment. In November 2019, the Ministry of Industry and Information Technology announced the list of the second batch of small varieties (shortage medicines) centralized production base construction units, and Guangyao Group was also listed. For these shorts of shortage medicines, companies enjoy the power of independent and reasonable pricing and directly hanging the network bidding and procurement. The medical insurance payment in some provinces will also be tilted with shortage drugs.
According to the report of the State Medical Insurance Bureau, the cost of the cost of drugs in Guangyao Baiyun Mountain is the time when the cost of drugs increased by the above period of time.
At present, the products involved in Guangyao Baiyun Mountain have been withdrawn or reduce prices in Shanxi, Anhui, Guizhou, Shandong and other places.
#Illegal lifting drug price ## Guangyao Baiyun Mountain ###
- END -
Sichuan yesterday's new local "1+1" was in Suining
The latest situation of the new type of coronary virus pneumonia in Sichuan Province(Published on August 12)At 00-24 on August 11, 1 new local diagnosis case in Sichuan (in Suining, a diagnosis of non
(Aid Aid Chronicle) Yuan Ye: "Specific Pioneer" on the epidemic prevention road
Reporter Liu YanFrom September 24, 2021, Yuan Ye, the tenth batch of supporting Xi...